In addition, as evidenced to be identical to LRP, MVP contributes to chemotherapy failure in several malignant tumors such as lung cancer, breast cancer, and hepatocellular carcinoma [17, 23, 24]. The gene discussed is MVP; the disease is breast carcinoma.